Cited by 1,743Cytokine Signaling Pathways and InteractionsProtein Tyrosine PhosphatasesNF-κB Signaling Pathways

The DOI matches its Crossref record; 152 of the 152 references it cites were found in a registry or an index.

STATs in oncogenesis

Bowman, Tammy, Garcia, Roy, Turkson, James, Jove, Richard·2000·Oncogene

DOI 10.1038/sj.onc.1203527

Open this paper in CoChat — free account

Abstract

Since their discovery as key mediators of cytokine signaling, considerable progress has been made in defining the structure-function relationships of Signal Transducers and Activators of Transcription (STATs). In addition to their central roles in normal cell signaling, recent studies have demonstrated that diverse oncoproteins can activate specific STATs (particularly Stat3 and Stat5) and that constitutively-activated STAT signaling directly contributes to oncogenesis. Furthermore, extensive surveys of primary tumors and cell lines derived from tumors indicate that inappropriate activation of specific STATs occurs with surprisingly high frequency in a wide variety of human cancers. Together, these findings provide compelling evidence that aberrant STAT activation associated with oncogenesis is not merely adventitious but instead contributes to the process of malignant transformation. These studies are beginning to reveal the molecular mechanisms leading to STAT activation in the context of oncogenesis, and candidate genes regulated by STATs that may contribute to oncogenesis are being identified. Recent studies suggest that activated STAT signaling participates in oncogenesis by stimulating cell proliferation and preventing apoptosis. This review presents the evidence for critical roles of STATs in oncogenesis and discusses the potential for development of novel cancer therapies based on mechanistic understanding of STAT signaling. Oncogene (2000).

Integrity signals

Registry

Crossref · 10.1038/sj.onc.1203527

Cites

152 of 152 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Jak-STAT Pathways and Transcriptional Activation in Response to IFNs and Other Extracellular Signaling Proteins
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
STATs and Gene Regulation
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells
Druker, B. J., Tamura, S., Buchdunger, E., Ohno-Jones, S., Segal, G. M., Fanning, S., Zimmermann, J., & Lydon, N. (1996) · Nature Medicine · doi:10.1038/nm0596-561 · Cited by 3,652
Stat3 as an Oncogene
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
A family of cytokine-inducible inhibitors of signalling
Starr, R., Willson, T. A., Viney, E. M., Murray, L. J. L., Rayner, J. R., Jenkins, B. J., Gonda, T. J., Alexander, W. S., Metcalf, D., Nicola, N. A., et al. (1997) · Nature · doi:10.1038/43206 · Cited by 2,066
Maximal activation of transcription by statl and stat3 requires both tyrosine and serine phosphorylation
Wen, Z., Zhong, Z., & Darnell, J. E. (1995) · Cell · doi:10.1016/0092-8674(95)90311-9 · Cited by 1,974
TRANSCRIPTIONAL RESPONSES TO POLYPEPTIDE LIGANDS: The JAK-STAT Pathway
Schindler, C., & Darnell, J. E. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.003201 · Cited by 1,808
Targeted Disruption of the Stat1 Gene in Mice Reveals Unexpected Physiologic Specificity in the JAK–STAT Signaling Pathway
Meraz, M. A., White, J. M., Sheehan, K. C. F., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81288-x · Cited by 1,656

Show all 152 references

Research works printed but not linked: 7

Gouilleux-Gruart V, Gouilleux F, Desaint C, Claisse JF, Capiod JC, Delobel J, Weber-Nordt R, Dusanter-Fourt I, Dreyfus F, Groner B and Prin L . 1996 Blood 87: 1692–1697 · DOI
Hallek M, Leif Bergsagel P and Anderson KC . 1998 Blood 91: 3–21 · DOI
Ho JM, Beattie BK, Squire JA, Frank DA and Barber DL . 1999 Blood 93: 4354–4364 · DOI
Liu RY, Fan C, Garcia R, Jove R and Zuckerman KS . 1999 Blood 93: 2369–2379 · DOI
Skorski T, Nieborowska-Skorska M, Wlodarski P, Wasik M, Trotta R, Kanakaraj P, Salomoni P, Antonyak M, Martinez R, Majewski M, Wong A, Perussia B and Calabretta B . 1998 Blood 91: 406–418 · DOI
Sun WH, Pabon C, Alsayed Y, Huang PP, Jandeska S, Uddin S, Platanias LC and Rosen ST . 1998 Blood 91: 570–576 · DOI
Wang YH, Wharton W, Garcia R, Kraker A, Jove R and Pledger WJ . 2000 Oncogene in press

Sorted by citations

Items 201–300 of 999

Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways
Sharma, D., Saxena, N. K., Vertino, P. M., & Anania, F. A. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01169 · Cited by 179
Thymoquinone inhibits proliferation, induces apoptosis and chemosensitizes human multiple myeloma cells through suppression of signal transducer and activator of transcription 3 activation pathway
Li, F., Rajendran, P., & Sethi, G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00874.x · Cited by 176
Activation of STAT3 by the Src Family Kinase Hck Requires a Functional SH3 Domain
Schreiner, S. J., Schiavone, A. P., & Smithgall, T. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204255200 · Cited by 176
Constitutive Activation of Signal Transducers and Activators of Transcription Predicts Vorinostat Resistance in Cutaneous T-Cell Lymphoma
Fantin, V. R., Loboda, A. P., Paweletz, C. P., Hendrickson, R. C., Pierce, J. W., Roth, J. A., Li, L., Gooden, F., Korenchuk, S., Hou, X., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6091 · Cited by 179
Protein Tyrosine Phosphatases as Potential Regulators of STAT3 Signaling
Kim, M., Morales, L. D., Jang, I., Cho, Y., & Kim, D. J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092708 · Cited by 181
STAT5 in Cancer and Immunity
Rani, A., & Murphy, J. J. (2015) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2015.0054 · Cited by 179
Expression of p-STAT3 in human colorectal adenocarcinoma and adenoma; correlation with clinicopathological factors
Kusaba, T., Nakayama, T., Yamazumi, K., Yakata, Y., Yoshizaki, A., Nagayasu, T., & Sekine, I. (2005) · Journal of Clinical Pathology · doi:10.1136/jcp.2004.023416 · Cited by 169
Maintenance of cancer stemness by miR-196b-5p contributes to chemoresistance of colorectal cancer cells via activating STAT3 signaling pathway
Ren, D., Lin, B., Zhang, X., Peng, Y., Ye, Z., Ma, Y., Liang, Y., Cao, L., Li, X., Li, R., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17971 · Cited by 173
Understanding Keloid Pathobiology From a Quasi-Neoplastic Perspective: Less of a Scar and More of a Chronic Inflammatory Disease With Cancer-Like Tendencies
Tan, S., Khumalo, N. P., & Bayat, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01810 · Cited by 176
Selective inhibition of STAT3 induces apoptosis and G1 cell cycle arrest in ALK-positive anaplastic large cell lymphoma
Amin, H. M., McDonnell, T. J., Ma, Y., Lin, Q. D., Fujio, Y., Kunisada, K., Leventaki, V., Das, P., Rassidakis, G. Z., Cutler, C. S., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207703 · Cited by 175
JAK-STAT Signal Inhibition Regulates Competition in the Drosophila Testis Stem Cell Niche
Issigonis, M., Tulina, N. M., de Cuevas, M., Brawley, C. M., Sandler, L., & Matunis, E. L. (2009) · Science · doi:10.1126/science.1176817 · Cited by 172
Stat1 negatively regulates angiogenesis, tumorigenicity and metastasis of tumor cells
Huang, S., Bucana, C. D., Arsdall, M. R. V., & Fidler, I. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205341 · Cited by 175
Constitutive Activation of Signal Transducer and Activator of Transcription 3 (STAT3) and Nuclear Factor κB Signaling in Glioblastoma Cancer Stem Cells Regulates the Notch Pathway
Garner, J. M., Fan, M., Yang, C. H., Du, Z., Sims, M. M., Davidoff, A. M., & Pfeffer, L. M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.477950 · Cited by 178
Inhibition of STAT3 dimerization and acetylation by garcinol suppresses the growth of human hepatocellular carcinoma in vitro and in vivo
Sethi, G., Chatterjee, S., Rajendran, P., Li, F., Shanmugam, M. K., Wong, K., Kumar, A. P., Senapati, P., Behera, A. K., Hui, K. M., et al. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-66 · Cited by 173
Epigallocatechin gallate and mitochondria—A story of life and death
de Oliveira, M. R., Nabavi, S. F., Daglia, M., Rastrelli, L., & Nabavi, S. M. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.12.027 · Cited by 174
ER stress: Can the liver cope?
Ji, C., & Kaplowitz, N. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.06.004 · Cited by 171
IL-6-STAT3 signaling and premature senescence
Kojima, H., Inoue, T., Kunimoto, H., & Nakajima, K. (2013) · JAK-STAT · doi:10.4161/jkst.25763 · Cited by 170
Stat3 activation in human endometrial and cervical cancers
Chen, C.-L., Hsieh, F.-C., Lieblein, J., Brown, J., Chan, C., Wallace, J. A., Cheng, G., Hall, B. M., & Lin, J. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603597 · Cited by 171
In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach: implications for cancer therapy
Xi, S., Gooding, W. E., & Grandis, J. R. (2004) · Oncogene · doi:10.1038/sj.onc.1208316 · Cited by 172
The molecular pathogenesis of acute promyelocytic leukaemia: implications for the clinical management of the disease
Mistry, A. R., Pedersen, E. W., Solomon, E., & Grimwade, D. J. (2003) · Blood Reviews · doi:10.1016/s0268-960x(02)00075-9 · Cited by 168
Stat3 and NF-κB activation prevents apoptosis in pancreatic carcinogenesis
Greten, F. R., Weber, C. K., Greten, T. F., Schneider, G., Wagner, M., Adler, G., & Schmid, R. M. (2002) · Gastroenterology · doi:10.1053/gast.2002.37075 · Cited by 169
NF-κB-Induced IL-6 Ensures STAT3 Activation and Tumor Aggressiveness in Glioblastoma
McFarland, B. C., Hong, S. W., Rajbhandari, R., Twitty, G. B., Gray, G. K., Yu, H., Benveniste, E. N., & Nozell, S. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078728 · Cited by 170
A Positive Autoregulatory Loop of LMP1 Expression and STAT Activation in Epithelial Cells Latently Infected with Epstein-Barr Virus
Chen, H., Hutt‐Fletcher, L. M., Cao, L., & Hayward, S. D. (2003) · Journal of Virology · doi:10.1128/jvi.77.7.4139-4148.2003 · Cited by 170
Activation of STAT3 and Bcl-2 and reduction of reactive oxygen species (ROS) promote radioresistance in breast cancer and overcome of radioresistance with niclosamide
Lu, L., Dong, J., Wang, L., Xia, Q., Zhang, D., Kim, H.-J., Yin, T., Fan, S., & Shen, Q. (2018) · Oncogene · doi:10.1038/s41388-018-0340-y · Cited by 168
Inhibition of interferon gamma signaling by the short chain fatty acid butyrate.
Klampfer, L., Huang, J., Sasazuki, T., Shirasawa, S., & Augenlicht, L. H. (2003) · PubMed · Cited by 168
TheDrosophilacytokine receptor Domeless controls border cell migration and epithelial polarization during oogenesis
Ghiglione, C., Devergne, O., Georgenthum, E., Carballès, F., Médioni, C., Cérézo, D., & Noselli, S. (2002) · Development · doi:10.1242/dev.00116 · Cited by 166
IL-21: An Executor of B Cell Fate
Konforte, D., Simard, N. N., & Paige, C. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803009 · Cited by 166
Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML
Zhou, J., Bi, C., Janakakumara, J. V., Liu, S.-C., Chng, W. J., Tay, K.-G., Poon, L.-F., Xie, Z., Palaniyandi, S., Yu, H., et al. (2009) · Blood · doi:10.1182/blood-2008-05-156422 · Cited by 172
Epidermal Growth Factor Receptor-Mediated Activation of Stat3 during Multistage Skin Carcinogenesis
Chan, K. S., Carbajal, S., Kiguchi, K., Clifford, J. L., Sano, S., & DiGiovanni, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3197 · Cited by 164
STAT3 activation abrogates growth factor dependence and contributes to head and neck squamous cell carcinoma tumor growth in vivo.
木島, 太., Niwa, H., Steinman, R. A., Drenning, S. D., Gooding, W. E., Wentzel, A. L., Xi, S., & Grandis, J. R. (2002) · PubMed · Cited by 164
Signal transducer and activator of transcription (STAT) signalling and T‐cell lymphomas
Mitchell, T. J., & John, S. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02091.x · Cited by 172
Deregulation of a STAT3-Interleukin 8 Signaling Pathway Promotes Human Glioblastoma Cell Proliferation and Invasiveness
de la Iglesia, N., Konopka, G., Lim, K., Nutt, C. L., Bromberg, J., Frank, D. A., Mischel, P. S., Louis, D. N., & Bonni, A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.5385-07.2008 · Cited by 169
PRL Activates the Cyclin D1 Promoter Via the Jak2/Stat Pathway
Brockman, J. L., Schroeder, M. D., & Schuler, L. A. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.4.0817 · Cited by 170
Brassinin inhibits STAT3 signaling pathway through modulation of PIAS-3 and SOCS-3 expression and sensitizes human lung cancer xenograft in nude mice to paclitaxel
Lee, J. H., Kim, C., Sethi, G., & Ahn, K. S. (2015) · Oncotarget · doi:10.18632/oncotarget.3443 · Cited by 162
Targeting cancer by binding iron: Dissecting cellular signaling pathways
Lui, G. Y. L., Kovačević, Ž., Richardson, V., Merlot, A. M., Kalinowski, D. S., & Richardson, D. R. (2015) · Oncotarget · doi:10.18632/oncotarget.4349 · Cited by 165
HDACi – Targets beyond chromatin
Buchwald, M., Krämer, O. H., & Heinzel, T. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.02.028 · Cited by 160
Celastrol Suppresses Growth and Induces Apoptosis of Human Hepatocellular Carcinoma through the Modulation of STAT3/JAK2 Signaling Cascade In Vitro and In Vivo
Rajendran, P., Li, F., Shanmugam, M. K., Kannaiyan, R., Goh, J. N., Wong, K., Wang, W., Khin, E. S. W., Tergaonkar, V., Kumar, A. P., et al. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0420 · Cited by 159
STAT3 and its targeting inhibitors in osteosarcoma
Liu, Y., Liao, S., Bennett, S., Tang, H., Song, D., Wood, D., Zhan, X., & Xu, J. (2020) · Cell Proliferation · doi:10.1111/cpr.12974 · Cited by 163
Linkage between STAT Regulation and Epstein-Barr Virus Gene Expression in Tumors
Chen, H., Lee, J. M., Zong, Y., Borowitz, M. J., Ng, M. H., Ambinder, R. F., & Hayward, S. D. (2001) · Journal of Virology · doi:10.1128/jvi.75.6.2929-2937.2001 · Cited by 163
STAT3 in cancer: A double edged sword
Avalle, L., Camporeale, A., Camperi, A., & Poli, V. (2017) · Cytokine · doi:10.1016/j.cyto.2017.03.018 · Cited by 160
X protein of hepatitis B virus modulates cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis
Diao, J., Garces, R. G., & Richardson, C. D. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00034-4 · Cited by 159
Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells.
Masuda, M., Suzui, M., Lim, J. T. E., & Weinstein, I. B. (2003) · PubMed · Cited by 154
Hepatitis C Virus (HCV) Constitutively Activates STAT-3 via Oxidative Stress: Role of STAT-3 in HCV Replication
Waris, G., Turkson, J., Hassanein, T., & Siddiqui, A. (2005) · Journal of Virology · doi:10.1128/jvi.79.3.1569-1580.2005 · Cited by 156
Self-citation
Retracted
Current Understanding on EGFR and Wnt/ -Catenin Signaling in Glioma and Their Possible Crosstalk
Paul, I., Bhattacharya, S., Chatterjee, A., & Ghosh, M. K. (2013) · Genes & Cancer · doi:10.1177/1947601913503341 · Cited by 158
Simvastatin Inhibits Renal Cancer Cell Growth and Metastasis via AKT/mTOR, ERK and JAK2/STAT3 Pathway
Fang, Z., Tang, Y., Fang, J., Zhou, Z., Xing, Z., Guo, Z., Guo, X., Wang, W., Jiao, W., Xu, Z., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062823 · Cited by 151
A Novel Platinum Compound Inhibits Constitutive Stat3 Signaling and Induces Cell Cycle Arrest and Apoptosis of Malignant Cells
Turkson, J., Zhang, S., Mora, L. B., Burns, A. C., Sebti, S. M., & Jove, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502694200 · Cited by 153
Self-citation
The Role of STAT-3 in the Induction of Apoptosis in Pancreatic Cancer Cells by Benzyl Isothiocyanate
Sahu, R. P., & Srivastava, S. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn470 · Cited by 150
Interleukin-6–dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family–independent survival pathway closely associated with Stat3 activation
Brocke-Heidrich, K., Kretzschmar, A. K., Pfeifer, G., Henze, C., Löffler, D., Koczan, D., Thiesen, H., Burger, R., Gramatzki, M., & Horn, F. (2003) · Blood · doi:10.1182/blood-2003-04-1048 · Cited by 151
Cytoplasmic transport of Stat3 by receptor‐mediated endocytosis
Bild, A. H., Turkson, J., & Jove, R. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf351 · Cited by 150
Self-citation
Functional Interaction of STAT3 Transcription Factor with the Coactivator NcoA/SRC1a
Giraud, S., Bienvenu, F., Avril, S., Gascan, H., Heery, D. M., & Coqueret, O. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111486200 · Cited by 149
Elevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancer
Lin, H.-J., Hsieh, F.-C., Song, H., & Lin, J. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602862 · Cited by 153
Chronic gastritis in the hypochlorhydric gastrin-deficient mouse progresses to adenocarcinoma
Zavros, Y. L., Eaton, K. A., Kang, W., Rathinavelu, S., Katukuri, V. K., Kao, J. Y., Samuelson, L. C., & Merchant, J. L. (2005) · Oncogene · doi:10.1038/sj.onc.1208407 · Cited by 149
Epstein-Barr Virus LMP1 Activates EGFR, STAT3, and ERK through Effects on PKCδ
Kung, C.-P., Meckes, D. G., & Raab‐Traub, N. (2011) · Journal of Virology · doi:10.1128/jvi.01703-10 · Cited by 157
Honokiol inhibits signal transducer and activator of transcription‐3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP‐1
Rajendran, P., Li, F., Shanmugam, M. K., Vali, S., Abbasi, T., Kapoor, S., Ahn, K. S., Kumar, A. P., & Sethi, G. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22954 · Cited by 148
Targeting Transcription Factors for Cancer Gene Therapy
Libermann, T. A., & Zerbini, L. F. (2006) · Current Gene Therapy · doi:10.2174/156652306775515501 · Cited by 153
More than a sidekick: the IL-6 family cytokine IL-11 links inflammation to cancer
Putoczki, T. L., & Ernst, M. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0410226 · Cited by 149
Molecular Biology of Head and Neck Cancer
Lam, D. K., & Schmidt, B. L. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-2527-6.00010-4 · Cited by 151
Regulation of Stat3 nuclear export
Bhattacharya, S., & Schindler, C. (2003) · Journal of Clinical Investigation · doi:10.1172/jci15372 · Cited by 147
A mechanism for epithelial–mesenchymal transition and anoikis resistance in breast cancer triggered by zinc channel ZIP6 and STAT3 (signal transducer and activator of transcription 3)
Högstrand, C., Kille, P., Ackland, M. L., Hiscox, S., & Taylor, K. M. (2013) · Biochemical Journal · doi:10.1042/bj20130483 · Cited by 146
Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells
Behera, R., Kumar, V., Lohite, K., Karnik, S., & Kundu, G. C. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp289 · Cited by 146
Tissue-Specific Autoregulation of the stat3 Gene and Its Role in Interleukin-6-Induced Survival Signals in T Cells
Narimatsu, M., Maeda, H., Itoh, S., Atsumi, T., Ohtani, T., Nishida, K., Itoh, M., Kamimura, D., Park, S., Mizuno, K., et al. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.19.6615-6625.2001 · Cited by 145
Phosphorylation of extracellular signal-regulated kinase 1 and 2, protein kinase B, and signal transducer and activator of transcription 3 are differently inhibited by an epidermal growth factor receptor inhibitor, EKB-569, in tumor cells and normal human keratinocytes
Nunes, M., Shi, C., & Greenberger, L. M. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.21.3.1 · Cited by 145
STATs as critical mediators of signal transduction and transcription: lessons learned from STAT5
Paukku, K., & Silvennoinen, O. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.09.001 · Cited by 147
An Update on the Multifaceted Roles of STAT3 in the Heart
Harhous, Z., Booz, G. W., Ovize, M., Bidaux, G., & Kurdi, M. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00150 · Cited by 145
Emerging roles for the non-canonical IKKs in cancer
Shen, R. R., & Hahn, W. C. (2010) · Oncogene · doi:10.1038/onc.2010.493 · Cited by 148
Curcumin suppresses constitutive activation of STAT‐3 by up‐regulating protein inhibitor of activated STAT‐3 (PIAS‐3) in ovarian and endometrial cancer cells
Saydmohammed, M., Joseph, D., & Syed, V. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22558 · Cited by 142
Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis
Yang, Y., Chang, Y., Huang, P., Chiou, G., Tseng, L., Chiou, S., Chen, M., Chen, M., Shih, Y., Chang, C., et al. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22806 · Cited by 147
Point mutations in the juxtamembrane domain of FLT3 define a new class of activating mutations in AML
Reindl, C., Bagrintseva, K., Vempati, S., Schnittger, S., Ellwart, J. W., Wenig, K., Hopfner, K., Hiddemann, W., & Spiekermann, K. (2006) · Blood · doi:10.1182/blood-2005-06-2596 · Cited by 143
Stat3 activation of NF-κB p100 processing involves CBP/p300-mediated acetylation
Nadiminty, N., Lou, W., Lee, S. O., Lin, X., Trump, D. L., & Gao, A. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509808103 · Cited by 137
Signal transducer and activator of transcription 3 activation is required for Asp816 mutant c-Kit–mediated cytokine-independent survival and proliferation in human leukemia cells
Ning, Z.-Q., Li, J., & Arceci, R. J. (2001) · Blood · doi:10.1182/blood.v97.11.3559 · Cited by 138
The Functions of Signal Transducers and Activators of Transcriptions 1 and 3 as Cytokine-Inducible Proteins
Cheon, H., Yang, J. B., & Stark, G. R. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0100 · Cited by 142
Capillarisin inhibits constitutive and inducible STAT3 activation through induction of SHP-1 and SHP-2 tyrosine phosphatases
Lee, J. H., Chiang, S. Y., Nam, D., Chung, W., Lee, J., Na, Y.-S., Sethi, G., & Ahn, K. S. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.12.008 · Cited by 138
Down-Regulation of the Interferon Signaling Pathway in T Lymphocytes from Patients with Metastatic Melanoma
Critchley-Thorne, R. J., Yan, N., Nacu, Ş., Weber, J. S., Holmes, S., & Lee, P. P. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040176 · Cited by 137
Bacterial N-acylhomoserine lactone-induced apoptosis in breast carcinoma cells correlated with down-modulation of STAT3
Li, L., Hooi, D. S. W., Chhabra, S. R., Pritchard, D., & Shaw, P. E. (2004) · Oncogene · doi:10.1038/sj.onc.1207612 · Cited by 137
Interleukin-6 Induced Basic Fibroblast Growth Factor-Dependent Angiogenesis in Basal Cell Carcinoma Cell Line via JAK/STAT3 and PI3-Kinase/Akt Pathways
Jee, S., Chu, C., Chiu, H.-C., Huang, Y., Tsai, W.-L., Liao, Y., & Kuo, M. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23497.x · Cited by 137
Modulation of Gene Expression and Tumor Cell Growth by Redox Modification of STAT3
Li, L., Cheung, S., Evans, E. L., & Shaw, P. E. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0894 · Cited by 140
Inhibition of Growth and Metastasis of Human Hepatocellular Carcinoma by Antisense Oligonucleotide Targeting Signal Transducer and Activator of Transcription 3
Li, W.-C., Ye, S., Sun, R., Liu, Y., Tang, Z., Kim, Y., Karras, J. G., & Zhang, H. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0484 · Cited by 139
Cucurbitacin I Suppressed Stem-Like Property and Enhanced Radiation-Induced Apoptosis in Head and Neck Squamous Carcinoma–Derived CD44+ALDH1+ Cells
Chen, Y., Chen, K.-H., Huang, P., Chen, Y., Chiou, G.-Y., Lo, W., Tseng, L., Hsu, H.-S., Chang, K., & Chiou, S. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0504 · Cited by 138
Identification and characterization of signal transducer and activator of transcription 3 recruitment sites within the epidermal growth factor receptor.
Shao, H., Cheng, H. Y., Cook, R. G., & Tweardy, D. J. (2003) · PubMed · Cited by 136
The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis
Rosen, D. G., Mercado‐Uribe, I., Yang, G. S., Bast, R. C., Amin, H. M., Lai, R. L., & Liu, J. (2006) · Cancer · doi:10.1002/cncr.22293 · Cited by 133
Serotonin receptor activation leads to neurite outgrowth and neuronal survival
Fricker, A. D., Rios, C., Devi, L. A., & Gomes, I. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.04.016 · Cited by 139
Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells
Yue, P., Zhang, X., Paladino, D., Sengupta, B., Ahmad, S., Holloway, R. W., Ingersoll, S. B., & Turkson, J. (2011) · Oncogene · doi:10.1038/onc.2011.409 · Cited by 137
Self-citation
Vasculogenesis and angiogenesis initiation under normoxic conditions through Wnt/β-catenin pathway in gliomas
Vallée, A., Guillevin, R., & Vallée, J.-N. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0032 · Cited by 137
Stat5a is tyrosine phosphorylated and nuclear localized in a high proportion of human breast cancers
Cotarla, I., Ren, S. V., Zhang, Y., Gehan, E. A., Singh, B., & Furth, P. A. (2003) · International Journal of Cancer · doi:10.1002/ijc.11619 · Cited by 139
Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr–Abl signal transduction and oncogenesis
Wilson, M. B., Schreiner, S. J., Choi, H.-J., Kamens, J., & Smithgall, T. E. (2002) · Oncogene · doi:10.1038/sj.onc.1206008 · Cited by 136
ERK and PI3K negatively regulate STAT-transcriptional activities in human melanoma cells: implications towards sensitization to apoptosis
Ma, K., Ivanov, V. N., Dong, J., & Ronai, Z. A. (2003) · Oncogene · doi:10.1038/sj.onc.1206598 · Cited by 132
Guggulsterone, a Farnesoid X Receptor Antagonist, Inhibits Constitutive and Inducible STAT3 Activation through Induction of a Protein Tyrosine Phosphatase SHP-1
Ahn, K. S., Sethi, G., Sung, B., Goel, A., Ralhan, R., & Aggarwal, B. B. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6696 · Cited by 135
The MEK-ERK Pathway Is Necessary for Serine Phosphorylation of Mitochondrial STAT3 and Ras-Mediated Transformation
Gough, D. J., Koetz, L., & Levy, D. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083395 · Cited by 137
Suppression of Signal Transducer and Activator of Transcription 3 Activation by Butein Inhibits Growth of Human Hepatocellular Carcinoma In Vivo
Rajendran, P., Ong, T. H., Chen, L., Li, F., Shanmugam, M. K., Vali, S., Abbasi, T., Kapoor, S., Sharma, A. K., Kumar, A. P., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1123 · Cited by 136
G protein coupled receptor signaling through the Src and Stat3 pathway: role in proliferation and transformation
Ram, P. T., & Iyengar, R. (2001) · Oncogene · doi:10.1038/sj.onc.1204186 · Cited by 132
Transcriptional Inactivation of STAT3 by PPARγ Suppresses IL-6-Responsive Multiple Myeloma Cells
Wang, L. H., Yang, X. Y., Zhang, X., Huang, J., Hou, J., Li, J., Xiong, H., Mihalic, K., Zhu, H., Xiao, W., et al. (2004) · Immunity · doi:10.1016/s1074-7613(04)00030-5 · Cited by 136
Formylpeptide Receptor FPR and the Rapid Growth of Malignant Human Gliomas
Zhou, Y., Bian, X., Le, Y., Gong, W., Hu, J., Zhang, X., Wang, L., Iribarren, P., Salcedo, R., Howard, O. M. Z., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji142 · Cited by 132
G-Quartet Oligonucleotides
Jing, N., Li, Y., Xiong, W., Sha, W., Jing, L., & Tweardy, D. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-4041 · Cited by 132
Stat3 contributes to keloid pathogenesis via promoting collagen production, cell proliferation and migration
Lim, C. P., Phan, T.-T., Lim, I. J., & Cao, X. (2006) · Oncogene · doi:10.1038/sj.onc.1209531 · Cited by 135
Neuregulin-1 Activates the JAK-STAT Pathway and Regulates Lung Epithelial Cell Proliferation
Liu, J., & Kern, J. A. (2002) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.4850 · Cited by 131
Constitutive activation of Stat5 promotes its cytoplasmic localization and association with PI3-kinase in myeloid leukemias
Harir, N., Pecquet, C., Kerenyi, M. A., Sonneck, K., Kovačic, B., Nyga, R., Brevet, M., Dhennin, I., Gouilleux‐Gruart, V., Beug, H., et al. (2006) · Blood · doi:10.1182/blood-2006-01-029918 · Cited by 130
Delineating an oncostatin M-activated STAT3 signaling pathway that coordinates the expression of genes involved in cell cycle regulation and extracellular matrix deposition of MCF-7 cells
Zhang, F., Li, C., Halfter, H., & Liu, J. (2003) · Oncogene · doi:10.1038/sj.onc.1206158 · Cited by 125
Progestins Induce Transcriptional Activation of Signal Transducer and Activator of Transcription 3 (Stat3) via a Jak- and Src-Dependent Mechanism in Breast Cancer Cells
Proietti, C. J., Salatino, M., Rosemblit, C., Carnevale, R. P., Pecci, A., Kornblihtt, A. R., Molinolo, A., Frahm, I., Charreau, E. H., Schillaci, R., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.12.4826-4840.2005 · Cited by 130
Reproductive Hormone-Induced, STAT3-Mediated Interleukin 6 Action in Normal and Malignant Human Ovarian Surface Epithelial Cells
Syed, V. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.8.617 · Cited by 130
The Interaction of Specific Peptide Aptamers With the DNA Binding Domain and the Dimerization Domain of the Transcription Factor Stat3 Inhibits Transactivation and Induces Apoptosis in Tumor Cells
Nagel‐Wolfrum, K., Buerger, C., Wittig, I., Butz, K., Hoppe‐Seyler, F., & Groner, B. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.170.2.3 · Cited by 132

Authors: Bowman, T., Garcia, R., Turkson, J., & Jove, R.
Affiliations: Moffitt Cancer Center (US)
University of South Florida (US)
ORCID: Turkson, James
Venue: Oncogene
Publisher: Springer Science and Business Media LLC
Published: 2000-05-25
Volume: 19
Issue: 21
Pages: 2474-2488
ISSN: 0950-9232 (ISSN-L)
1476-5594
DOI: 10.1038/sj.onc.1203527
OpenAlex: W2024282024
Cited by: 1,743
References: 152
Citations by year: 2026: 16 · 2025: 18 · 2024: 18 · 2023: 22 · 2022: 39 · 2021: 48 · 2020: 44 · 2019: 45 · 2018: 59 · 2017: 63 · 2016: 58 · 2015: 104 · 2014: 80 · 2013: 82 · 2012: 89
FWCI: 7.25
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Oncogene (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
Keywords: STAT, signal transducer and activator of transcription, carcinogenesis, STAT3, STAT5, malignant transformation, cytokine signaling, cell proliferation, apoptosis, cancer therapy targets, cancer cell lines
MeSH terms: Animals, Cell Transformation, Neoplastic, DNA-Binding Proteins, Humans, Neoplasms, Phosphorylation, Phosphoserine, Protein-Tyrosine Kinases, Signal Transduction, Oncogene Proteins, Trans-Activators, Gene Expression Regulation, Neoplastic, STAT1 Transcription Factor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

STATs in oncogenesis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks